Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-716-0 | CAS number: 1345-07-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Toxicity to reproduction
Administrative data
- Endpoint:
- screening for reproductive / developmental toxicity
- Remarks:
- based on test type (migrated information)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2013-01-16 to 2013-03-06
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: GLP and OECD guideline compliant
Cross-reference
- Reason / purpose for cross-reference:
- reference to other study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 013
- Report date:
- 2013
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 421 (Reproduction / Developmental Toxicity Screening Test)
- Version / remarks:
- adopted 27.07.1995
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.3500 (Preliminary Developmental Toxicity Screen)
- Version / remarks:
- July 2000
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Limit test:
- no
Test material
- Reference substance name:
- Dibismuth trisulphide
- EC Number:
- 215-716-0
- EC Name:
- Dibismuth trisulphide
- Cas Number:
- 1345-07-9
- Molecular formula:
- Bi2S3
- IUPAC Name:
- dibismuth trisulphide
- Test material form:
- solid: particulate/powder
- Remarks:
- migrated information: powder
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Species and strain: Hsd.Brl.Han:Wist rat
- Source: Toxi-Coop Zrt. Cserkesz u. 90. H-1103 Budapest Hungary
- Age at study initiation: 71-76 days old
- Weight at study initiation: (P) Males: 296-340 g; Females: 178-215 g;
- Fasting period before study:
- Housing: Before mating: 2 animals of the same sex/ cage; mating: 1 male and 1 female / cage; pregnant females will be housed individually. Males after mating: 2 animals / cage
- Diet: ssniff® SM R/M-Z+H "Autoclavable complete feed for rats and mice – breeding and maintenance" produced by ssniff Spezialdiäten GmbH, D-59494 Soest, Germany ad libitum, and tap water from municipal supply, as for human consumption, from 500 mL bottles ad libitum.
- Water: drinking water
- Acclimatization time: 6 days
ENVIRONMENTAL CONDITIONS
- Temperature: 22 ± 3 °C
- Humidity: 30 - 70 %
- Air changes: 8-12 air exchanges/hour by central air-condition system.
- Photoperiod: 12 hours daily, from 6.00 a.m. to 6.00 p.m.
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- other: Sunflower oil (Helianthii annui oleum raffinatum)
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
Formulations were prepared in the formulation laboratory of the Test Facility daily.
VEHICLE
- Justification for use and choice of vehicle (if other than water): The test item is not soluble in water therefore sunflower oil was used for preparing formulations appropriate for oral administration. Sunflower oil is a suitable vehicle to facilitate formulation analysis for the test item
- Concentration in vehicle: The test item was formulated in the vehicle in concentrations of 500, 150 and 50 mg/mL. - Analytical verification of doses or concentrations:
- yes
- Frequency of treatment:
- once per day
Doses / concentrations
- Remarks:
- Doses / Concentrations:
100, 300 and 1000 mg/kg bw/day
Basis:
other: nominal in vehicle
- No. of animals per sex per dose:
- 12 per sex and dose
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- The dose setting with 1000, 300 and 100 mg/kg bw/day based on findings obtained in a previous 14-Day Oral Gavage Dose Range Finding Study
with Dibismuth Trisulfide in the Rat (Toxi-Coop study no. 559.400.3811) and was in agreement with the Sponsor. The high dose was chosen with the aim of inducing toxic effects but no mortality or severe suffering of animals. The low dose was chosen to induce no toxic effect. - Positive control:
- not applicable
Examinations
- Parental animals: Observations and examinations:
- CAGE SIDE OBSERVATIONS: Yes
- Time schedule: Animals were inspected for signs of morbidity and mortality twice daily (at the beginning and end of each working day).
DETAILED CLINICAL OBSERVATIONS: Yes
- Time schedule: General clinical observations were made once a day, after treatment at approximately the same time, considering the peak period of anticipated effects after dosing. Pertinent behavioral changes, signs of difficult or prolonged parturition and all signs of toxicity including mortality were recorded including onset, degree and duration of signs.
BODY WEIGHT: Yes
- Time schedule for examinations: All parental animals were weighed with an accuracy of 1 g. Parental males were weighed on the first day of dosing (day 0), at least weekly thereafter and at termination. Parental females were weighed on the first day of dosing (day 0) then weekly, on gestation days 0, 7, 14 and 21 and on post-partal days 0 (within 24 hours after parturition) and 4, as well as on the day of necropsy. Body weight of the female animals were additionally weighed on gestational days 10 and 17 in order to give accurate treatment volumes, but these data will not be evaluated statistically. Body weight data were reported individually for adult animals.
FOOD CONSUMPTION:
The food consumption was determined weekly by reweighing the nonconsumed diet with an accuracy of 1 g during the treatment period except
mating days (pre-mating and post mating for male animals and nonpregnant females, during pre-mating, gestation days 0, 7, 14 and 21, lactation
days 0 and 4 for dams). - Oestrous cyclicity (parental animals):
- not examined
- Sperm parameters (parental animals):
- The investigated organs of reproductive system (testes, epididymides) were histologically normal. The various spermatogenic cells
(the spermatogonia, the spermatocytes, the spermatids and spermatozoa), representing different phases in the development and differentiation of the spermatozoons and the interstitial cells were the same in quantity and morphologically. Compared to the concurrent control, epididymides
were histologically normal in all animals. - Litter observations:
- Each litter was examined as soon as possible after delivery to establish the number and sex of pups, stillbirths, live births, runts (pups that are
significantly smaller than normal pups), and the presence of gross abnormalities. Live pups were counted, sexed and litters were weighed within 24 hours of parturition (on the day when parturition was complete) and on day 4 postpartum with an accuracy of 0.1 g.In addition to the observations on parent animals, any abnormal behavior of the offspring was monitored. All the litters were checked and recorded daily for the number of viable
and dead pups. The pups found dead were subjected to necropsy by a macroscopic examination. On day of birth, a lung flotation test was
performed on all dead pups to separate stillborns from those that died after delivery. The lung flotation test is negative for stillborns (pups that
died intrauterine) but positive for pups that died after delivery. - Postmortem examinations (parental animals):
- Pathology
Gross necropsy was performed on each animal one day after the last treatment (day of sacrificing). Animals were anesthetized by Isofluran (details are presented in "Details of Other Materials") and then were exsanguinated. After examination of the external appearance the cranial, thoracic and abdominal cavities were opened and the appearance of the tissues and organs were observed, and any abnormality was recorded with details of
the location, color, shape and size. Special attention was paid to the organs of the reproductive system. The number of implantation sites and of
corpora lutea was recorded. The testes, epididymides and brain of all male adult animals were weighed. The uterus with cervix, vagina, testes,
epididymides (total and cauda), prostate, and seminal vesicles with coagulating glands, ovaries, pituitary of all adult animals were preserved.
Testes and epididymides were fixed in modified Davidson solution, all other organs in 4 % buffered formaldehyde solution. - Postmortem examinations (offspring):
- Pathology
Pups were carefully examined for gross (external) abnormalities and euthanized on postnatal day 4. - Statistics:
- The statistical evaluation of appropriate data (marked †above) were performed with the statistical program package SPSS PC+4.0. The homogeneity of variance between groups was checked by Bartlett’s homogeneity of variance test. Where no significant heterogeneity was detected a one-wayanalysis of variance (ANOVA) was carried out. If the obtained result was significant Duncan Multiple Range test was used to access the significance of intergroup differences. Getting significant result at Bartlett’s test the Kruskal-Wallis analysis of variance was used and the inter-group
comparisons were performed using Mann-Whitney U-test. Chi2 test was performed if feasible. The frequency of clinical signs, pathology and
histopathology findings were calculated. Results were evaluated in comparison with values of control group (i.e.control value). - Reproductive indices:
- The examined parameters of reproductive performance were not affected by the treatment with the test item at 1000, 300 or 100 mg/kg bw/day
doses in male or female animals. - Offspring viability indices:
- Parameters listed below were evaluated
- Litter weight on postnatal days 0 and 4,
- Mean body weight gain per litter between postnatal days 0-4
- Number of live births per litter, and number of viable pups per litter on postnatal days 0 and 4
- Survival Index of pups on postnatal day 4
- Sex ratio % (on postnatal days 0 and 4)
There was no test item related effect on pup’s mortality.There were no test item related differences between the control and test item treated groups in the ration or in the litter means of genders on postnatal days 0 or 4. Test item related clinical signs were not detected in the offspring.
The number and percentage of pups with findings (cold, no milk in the stomach, pale) were the highest in the control group. Test item effect on the
body weight development of offspring was not found.
The mean litter weights and mean pup weights were similar in the control and in all test item treated groups on postnatal days 0 and 4.
No test item related macroscopic alterations were found in offspring subjected to gross pathological examination.
Results and discussion
Results: P0 (first parental generation)
General toxicity (P0)
- Clinical signs:
- no effects observed
- Body weight and weight changes:
- no effects observed
- Food consumption and compound intake (if feeding study):
- no effects observed
- Organ weight findings including organ / body weight ratios:
- no effects observed
- Histopathological findings: non-neoplastic:
- no effects observed
- Other effects:
- no effects observed
Reproductive function / performance (P0)
- Reproductive function: oestrous cycle:
- not examined
- Reproductive function: sperm measures:
- no effects observed
- Reproductive performance:
- no effects observed
Details on results (P0)
Mortality
There was no test item related mortality at any dose level (1000, 300 and 100 mg/kg bw/day).
Clinical observation
The behavior and physical condition of animals were normal during the entire observation period (pre-mating, mating, post-mating, gestation and
lactation periods) in each group.
BODY WEIGHT AND FOOD CONSUMPTION (PARENTAL ANIMALS)
Body weight and body weight gain The body weight development was undisturbed in the test item treated animals at each dose level (1000, 300 and 100 mg/kg bw/day) during the entire treatment period (pre-mating, mating, post-mating, gestation and lactation periods).
Food consumption
The mean daily food consumption was not affected by the test item in male or female animals at 1000, 300 and 100 mg/kg bw/day during the study (premating and post mating for male animals, during pre-mating for dams and non-pregnant females, during gestation and lactation periods for
dams).
REPRODUCTIVE FUNCTION: (PARENTAL ANIMALS)
Reproduction
There were no test item related differences between the control and test item treated groups in delivery data of dams and in the reproductive
performance of male and female animals.
ORGAN WEIGHTS (PARENTAL ANIMALS)
There were no test item related changes in brain, testes and epididymides weights.
HISTOPATHOLOGY (PARENTAL ANIMALS)
Histopathological examinations of male and female genital organs (ovaries, testes and epididymides) did not reveal any toxic or other test item
related changes at any dose level.
NECROPSY (PARENTAL ANIMALS)
Specific macroscopic alterations related to the test item were not found during the necropsy.
Effect levels (P0)
open allclose all
- Dose descriptor:
- NOEL
- Remarks:
- for general toxicity
- Effect level:
- 1 000 mg/kg bw/day
- Sex:
- male/female
- Dose descriptor:
- NOEL
- Remarks:
- for reproductive performance
- Effect level:
- 1 000 mg/kg bw/day
- Sex:
- male/female
Results: F1 generation
General toxicity (F1)
- Clinical signs:
- no effects observed
- Mortality / viability:
- no mortality observed
- Body weight and weight changes:
- no effects observed
- Sexual maturation:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Histopathological findings:
- not examined
Details on results (F1)
Negative effects of the test item on offspring development (mortality, clinical signs, and body weight and necropsy findings) were not detected
between postnatal days 0 and 4.
Effect levels (F1)
- Dose descriptor:
- NOEL
- Generation:
- F1
- Effect level:
- 1 000 mg/kg bw/day
- Sex:
- male/female
Overall reproductive toxicity
- Reproductive effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- According to OECD guideline 421 a Reproduction/Developmental Toxicity Screening Test with dibismuth trisulfide in the rats was performed. Under the conditions of the present study dibismuth trisulfide did not cause toxic changes and did not influence the reproductive performance (gonad function, mating behavior, conception, pregnancy, parturition) in parental male and female Hsd.Brl.Han: Wistar rats or development of the F1 offspring from conception to day 4 post-partum after repeated dose oral administration at 1000, 300 or 100 mg/kg bw/day. Based on these observations the No Observed Effect Levels (NOEL) were determined as follows:
NOEL for male rats: 1000 mg/kg bw/day
NOEL for female rats: 1000 mg/kg bw/day
NOEL for reproductive performance of the male rats: 1000 mg/kg bw/day
NOEL for reproductive performance of the female rats: 1000 mg/kg bw/day
NOEL for F1 Offspring: 1000 mg/kg bw/day - Executive summary:
According to OECD guideline 421 a Reproduction/Developmental Toxicity Screening Test with dibismuth trisulfide in the rats was performed. Four groups of Hsd.Brl.Han:Wist rats (n=12/sex/group) were administered orally (by gavage) once a day at 0 (vehicle only), 1000, 300 and 100 mg/kg bw/day at concentrations of 500 mg/mL, 150 and 50 mg/mL corresponding to 2 mL/kg bw dose volume. The suitability of the chosen vehicle for the test item at the intended concentrations was analytically verified up front. Concentration of the test item in the dosing formulations was checked twice during the study. Dibismuth trisulfide concentrations in the dosing formulations varied in the range of 84 and 97 % of the nominal values at both analytical occasions, thereby confirming proper dosing. All animals of the parent (P) generation received test item or vehicle prior to mating (14 days) and throughout mating. Test item or vehicle was administered to male animals post mating up to the day before the necropsy (altogether for 43 days). For females, test item was administered through the gestation period and up to lactation days 3-8 i.e. up to the day before the necropsy (altogether for 43 or 49 days). Observations included mortality, clinical signs, body weight, food consumption, mating, pregnancy and delivery process, as well as development of offsprings. The dams were allowed to litter, and rear their young up to day 4 postpartum. Litters were weighed and offsprings were observed for possible abnormalities and were euthanized on postnatal day 4. All parental animals were subjected to gross pathology one day after the last treatment. Histopathology examination was performed on reproductive organs (testes, epididymides and ovaries) in the control and high dose groups. The reproductive organs of non-pregnant females and males cohabited with in the low dose group were also processed and evaluated histologically. The results were interpreted comparing treatment groups with respect to controls, which were treated concurrently with the vehicle (sunflower oil) only.
Under the conditions of the present study Dibismuth trisulfide did not cause toxic changes and did not influence the reproductive performance (gonad function, mating behavior, conception, pregnancy, parturition) in parental male and female Hsd.Brl.Han: Wistar rats or development of the F1 offspring from conception to day 4 post-partum after repeated dose oral administration at 1000, 300 or 100 mg/kg bw/day. Based on these
observations the No Observed Effect Levels (NOEL) were determined as follows:
NOEL for male rats: 1000 mg/kg bw/day
NOEL for female rats: 1000 mg/kg bw/day
NOEL for reproductive performance of the male rats: 1000 mg/kg bw/day
NOEL for reproductive performance of the female rats: 1000 mg/kg bw/day
NOEL for F1 Offspring: 1000 mg/kg bw/day
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.